METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications

Dongdong Jian, Ying Wang, Liguo Jian, Hao Tang, Lixin Rao, Ke Chen, Zhen Jia, Wanjun Zhang, Yiran Liu, Chen Xu,

Theranostics · 2020 · 287 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

A modification and inducing endothelial cell inflammatory response as well as atherosclerotic plaque formation. Decreased expression of METTL14 can inhibit endothelial inflammation and atherosclerosis development. Therefore, METTL14 may serve as a potential target for the clinical treatment of atherosclerosis.

References

39